Neonatal mortality · all women who become pregnant or were 12 or less weeks' pregnant at the time of the intervention
1 finding from 1 review
Maternal anaemia at or near term (All) · all women who become pregnant or were 12 or less weeks' pregnant at the time of the intervention
1 finding from 1 review
Maternal red blood cell folate at or near term (All) · all women who become pregnant or were 12 or less weeks' pregnant at the time of the intervention
1 finding from 1 review
Serum folate at or near term · all women who become pregnant or were 12 or less weeks' pregnant at the time of the intervention
1 finding from 1 review
Intervention not reported
Reversion · People with induced SVT
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Reversion · Patients presenting to emergency department with SVT
1 finding from 1 review
no estimate extracted
Studies not reported
Low
PASI score (scale range from 0 to 72 (higher score indicates more severe psoriasis)) · psoriasis
1 finding from 1 review
Quality of life (QoL) ‐ not measured · psoriasis
1 finding from 1 review
Common nuisance AEs (not leading to treatment discontinuation) · psoriasis
It is very uncertain whether FAE changes common nuisance AEs (not leading to treatment discontinuation) compared with MTX (very low certainty).
1 finding from 1 review
PASI 50 · psoriasis
It is very uncertain whether FAE changes PASI 50 compared with MTX (very low certainty).
1 finding from 1 review
Percentage of participants reaching PASI 75 · psoriasis
It is very uncertain whether FAE changes PASI 75 compared with MTX (very low certainty).
1 finding from 1 review
PASI 90 · psoriasis
It is very uncertain whether FAE changes PASI 90 compared with MTX (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · psoriasis
1 finding from 1 review
QoL · psoriasis
1 finding from 1 review
Common nuisance AEs (not leading to treatment discontinuation) · psoriasis
FAE probably leads to higher common nuisance AEs (not leading to treatment discontinuation) compared with placebo (moderate certainty).
1 finding from 1 review
PASI 50 · psoriasis
FAE may leads to higher PASI 50 compared with placebo (low certainty).
1 finding from 1 review
Percentage of participants reaching PASI 75 · psoriasis
1 finding from 1 review
PASI 90 ‐ not measured · psoriasis
1 finding from 1 review
PASI score (scale range from 0 to 72 (higher score indicates more severe psoriasis)) · psoriasis
1 finding from 1 review
Withdrawals due to adverse events · psoriasis
It is very uncertain whether FAE changes AEs leading to treatment discontinuation compared with MTX (very low certainty).
1 finding from 1 review